Phase I/II Study of SY-5007, a RET Inhibitor, in Patients With RET-altered Advanced Solid Tumor

Clinical trial NCT05278364 · UNKNOWN

Trial details

NCT number: NCT05278364
Sponsor: Shouyao Holdings (Beijing) Co. LTD
Status: UNKNOWN
Phase: Phase 1, Phase 2
Study type: INTERVENTIONAL

Non-Small Cell Lung Cancer Medullary Thyroid Cancer Solid Tumor

Start date: 2021-04-23
Primary completion: 2025-01-01
Enrollment: 184

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.